By Dr. Kerri Brackney

“I’m not a baby!” my 10-year-old son insisted again recently – frustrated in the way only a youngest child can be. He resists that identity, and I understand that. But the truth is less negotiable than he believes.

“You’ll always be my baby,” I told him, as I always do. This time I added, “Not just because you’re my last-born, but because a piece of you will always be a part of me.”

I explained that there is a real, measurable scientific phenomenon called microchimerism.

Though the term sounds obscure, the concept is straightforward: a small number of cells from one individual can live and replicate inside the body of another. Cells cross the placenta in both directions: the baby leaves cells behind in the mother, the mother leaves cells behind in the baby.

This isn’t rare – it’s been demonstrated consistently after pregnancy in over a quarter of women who were tested.

Fetal microchimeric cells have been identified all throughout a mother’s body – in her heart, liver, thyroid, brain, and even throughout her immune system.

These are not passive remnants or merely DNA fragments. Some of them behave like stem cells, capable of adapting to their local environment. In certain contexts, they appear to participate in tissue repair, integrating into maternal organs in a way that suggests function, not merely presence.

Pregnancy, then, is not simply a period of carrying. It is a period of biological integration. What makes this even more striking isn’t just where these cells go, but how long they stay. Studies have found fetal cells circulating in maternal blood decades after delivery – in one case nearly four decades later. In others, the cells are embedded in her organs, persisting quietly. Not breaking down or disappearing.

Surprisingly, this isn’t limited to term pregnancies. Fetal microchimerism has been detected even after early miscarriage. The duration of the pregnancy does not determine whether an exchange occurred.

Furthermore, the traffic is bidirectional. Maternal cells cross into the fetus as well, meaning that a child is born carrying cells from his or her mother—and twins often carry cells from their co-twin, representing horizontal transfer. Biologically, this creates a layered inheritance that is far more dynamic than genetics alone.

So what does all of this mean?

At a minimum, it changes how we understand pregnancy. Pregnancy isn’t a temporary state followed by a completely clean separation – there can be a lasting biological relationship. A mother doesn’t simply “return to baseline” after pregnancy concludes. Her body can be altered at the cellular level in ways that persist for decades.

There are hints – still being studied – that these cells may contribute to healing. Some research suggests roles in tissue repair, modulation of immune responses, even possible protection against certain cancers. At the same time, the interaction may not be purely beneficial. High levels of microchimerism have been associated with autoimmune conditions such as lupus, thyroid disease and pregnancy complications like preeclampsia. The biological integration that can support healing may, under certain conditions, go awry and contribute to dysfunction. That tension matters. It reflects something deeper about human biology in a fallen world: complex systems can demonstrate brokenness. The maternal-fetal relationship isn’t just biologically complex. It is emotionally and spiritually complex, too.

But complexity doesn’t diminish the significance of microchimerism. It sharpens it. For a mother holding her baby – especially in those early months when everything feels so immediate and consuming – it’s easy to think of pregnancy as something that has ended, something now in the past. The physical challenges are over and delivery is in the rearview mirror. Recovery is underway.

Microchimerism argues otherwise. Pregnancy isn’t over – at least, not in the way we tend to think.

A child’s presence isn’t confined to a pregnancy test, ultrasounds, photographs, or even to the arms holding him. That presence extends into the mother’s own tissues – quiet, microscopic, and enduring. Her body has been changed in a way that cannot reverse, even after a miscarriage in which she lost the opportunity to hold her little one in her arms.

Perhaps this is just one small way that God fulfills His promise: to bless those who love Him and keep His commandments, to the thousandth generation. His steadfast love and faithfulness connects us across generations in ways that are both breathtaking and enduring.

There is a kind of clarity in that. The language we use as mothers – my baby – is often dismissed as purely emotion, even sentimental. But biology doesn’t dismiss it, rather biology reinforces it.

The connection is not just felt. It’s built in by our Creator.

Kerri Brackney, MD
Dr. Brackney is a Maternal Fetal Medicine physician in Memphis, TN

Sources

1. Adams Waldorf KM, Gammill HS, Lucas J, Aydelotte TM, Leisenring WM, Lambert NC, Nelson JL. Dynamic changes in fetal microchimerism in maternal peripheral blood mononuclear cells, CD4+ and CD8+ cells in normal pregnancy. Placenta. 2010 Jul;31(7):589-94. doi: 10.1016/j.placenta.2010.04.013. Epub 2010 May 31. PMID: 20569981; PMCID: PMC2923456.
2. Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, Nelson JL. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood. 1999 Mar 15;93(6):2033-7. PMID: 10068676.
3. Fugazzola L, Cirello V, Beck-Peccoz P. Microchimerism and endocrine disorders. J Clin Endocrinol Metab. 2012 May;97(5):1452-61. doi: 10.1210/jc.2011-3160. Epub 2012 Mar 7. PMID: 22399520.
4. Jacobsen DP, Fjeldstad HE, Sugulle M, Johnsen GM, Olsen MB, Kanaan SB, Staff AC. Fetal microchimerism and the two-stage model of preeclampsia. J Reprod Immunol. 2023 Sep;159:104124. doi: 10.1016/j.jri.2023.104124. Epub 2023 Jul 25. PMID: 37541161.
5. Khosrotehrani K, Bianchi DW. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci. 2005 Apr 15;118(Pt 8):1559-63. doi: 10.1242/jcs.02332. PMID: 15811948.
6. Khosrotehrani K, Johnson KL, Cha DH, Salomon RN, Bianchi DW. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA. 2004 Jul 7;292(1):75-80. doi: 10.1001/jama.292.1.75. PMID: 15238593.
7. Nelson JL. The otherness of self: microchimerism in health and disease. Trends Immunol. 2012 Aug;33(8):421-7. doi: 10.1016/j.it.2012.03.002. Epub 2012 May 19. PMID: 22609148; PMCID: PMC3516290.
8. Nelson JL, Lambert NC. The when, what, and where of naturally-acquired microchimerism. Immunopathol. 2025 Mar 11;47(1):20. doi: 10.1007/s00281-024-01029-2. PMID: 40067465.
9. Peterson SE, Nelson JL, Guthrie KA, Gadi VK, Aydelotte TM, Oyer DJ, Prager SW, Gammill HS. Prospective assessment of fetal-maternal cell transfer in miscarriage and pregnancy termination. Hum Reprod. 2012 Sep;27(9):2607-12. doi: 10.1093/humrep/des244. Epub 2012 Jun 29. PMID: 22752611; PMCID: PMC3415291.
10. Sedov E, McCarthy J, Koren E, Fuchs Y. Fetomaternal microchimerism in tissue repair and tumor development. Dev Cell. 2022 Jun 20;57(12):1442-1452. doi: 10.1016/j.devcel.2022.05.018. Epub 2022 Jun 13. PMID: 35700729.